NCT01095757
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
NCT00059839
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
- Phoenix Children's Hospital Phoenix, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Southern California Permanente Medical Group Downey, California, United States
NCT01309737
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Burke Pharmaceutical Research Hot Springs, Arkansas, United States
- Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
- University of California San Diego La Jolla, California, United States
Completed
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
NCT01504776
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Georgia Regents University Augusta, Georgia, United States
NCT01276639
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
- Locations
-
- Radiant Research, Inc. Birmingham, Alabama, United States
- University of California, Irvine - Dermatology Research Irvine, California, United States
- Skin Surgery Medical Group, Inc. San Diego, California, United States
- Clinical Science Institute Santa Monica, California, United States
NCT00057811
- Conditions
- Burkitt Lymphoma, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, +30 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
NCT00964873
- Conditions
- ALL, AML, Acute Lymphoblastic Leukemia, +27 more
- Locations
-
- Tampa, Florida, United States
- Baltimore, Maryland, United States
- Durham, North Carolina, United States
NCT00461084
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00004258
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
- Locations
-
- Indiana University Cancer Center Indianapolis, Indiana, United States
NCT01290120
- Conditions
- B-ALL, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy
- Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy
- S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy
- Onco-Ematologia - Ospedale Civile Noale, (ve), Italy